BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21164064)

  • 1. Possible case of levofloxacin-induced thrombocytopenia.
    Salloum R; Liu CY; Weise AM
    Am J Health Syst Pharm; 2011 Jan; 68(1):43-6. PubMed ID: 21164064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia associated with the use of levofloxacin.
    Garber SM; Pound MW; Miller SM
    Am J Health Syst Pharm; 2009 Jun; 66(11):1014-9. PubMed ID: 19451612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin-induced severe thrombocytopenia.
    Polprasert C; Prayongratana K
    J Med Assoc Thai; 2009 Jun; 92 Suppl 3():S69-71. PubMed ID: 19702070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe thrombocytopenia possibly associated with TMP/SMX therapy.
    Yamreudeewong W; Fosnocht BJ; Weixelman JM
    Ann Pharmacother; 2002 Jan; 36(1):78-82. PubMed ID: 11816265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pseudothrombocytopenia during antibiotic administration].
    Kinoshita Y; Yamane T; Kamimoto A; Oku H; Iwata Y; Kobayashi T; Hino M
    Rinsho Byori; 2004 Feb; 52(2):120-3. PubMed ID: 15027315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycemia associated with levofloxacin in Type 2 diabetic patients receiving polytherapy: two case reports.
    Micheli L; Sbrilli M; Nencini C
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):302-6. PubMed ID: 22456302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
    Russell KN; Schnabel JG; Rochetto RP; Tanner MC
    Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe thrombocytopenia associated with alatrofloxacin.
    Gales BJ; Sulak LB
    Ann Pharmacother; 2000 Mar; 34(3):330-4. PubMed ID: 10917380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.
    Digwood-Lettieri S; Reilly KJ; Haith LR; Patton ML; Guilday RJ; Cawley MJ; Ackerman BH
    Pharmacotherapy; 2002 Jun; 22(6):789-93. PubMed ID: 12066972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.
    Morganroth J; Dimarco JP; Anzueto A; Niederman MS; Choudhri S;
    Chest; 2005 Nov; 128(5):3398-406. PubMed ID: 16304291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced immune thrombocytopenia due to moxifloxacin.
    Coker TJ
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23329709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of levofloxacin treatment of community--acquired pneumonia in hospitalized patients].
    Karwat KJ; Grabczak M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):77-9. PubMed ID: 17175982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.